The role radiotherapy in non-small-cell lung cancer

Technical advances in stereotactic radiotherapy have resulted in marked improvements in local control for medically inoperable stage I NSCLC. A better integration of chemo-radiotherapy in stage III NSCLC can improve survival for these patients. Although concurrent chemo-radiotherapy appears to be superior, it is clear that this approach is not suitable for all patients. Patients are likely to derive maximal benefit from these recent advances in the treatment of thoracic malignancies when close collaboration exists within multidisciplinary teams involved in the treatment of NSCLC